about
Comparison of two peptide radiotracers for prostate carcinoma targetingAnti-digoxin Fab variants generated by phage display.Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancerProduction of the first effective hyperimmune equine serum antivenom against Africanized bees.Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200.Biosimilars advancements: Moving on to the future.Genetic analyses of Per.C6 cell clones producing a therapeutic monoclonal antibody regarding productivity and long-term stability.Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.Evaluation of GX1 and RGD-GX1 peptides as new radiotracers for angiogenesis evaluation in experimental glioma models.Radiolabeled NGR phage display peptide sequence for tumor targeting.Generation of a Chinese hamster ovary cell line producing recombinant human glucocerebrosidase.Pathogenic Leptospira species acquire factor H and vitronectin via the surface protein LcpA.Strategies for clone detection, selection and isolation in Per.C6 cells - case for Rebmab100.Radiolabeled GX1 Peptide for Tumor Angiogenesis Imaging.Adaptation of glucocerebrosidase-producing CHO cells to serum-free suspension culture.Comparison of humanized IgG and FvFc anti-CD3 monoclonal antibodies expressed in CHO cells.Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma.Bispecific monoclonal antibody anti-CD3 x anti-tenascin: an immunotherapeutic agent for human glioma.Multiparametric analyses of hybridoma growth on glass cylinders in a packed-bed bioreactor system with internal aeration. Serum-supplemented and serum-free media comparison for MAb productionHumanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigenHuman Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects andLUVs Recovered with Chitosan: A New Preparation for Vaccine DeliveryDesign and synthesis of germline-based hemi-humanized single-chain Fv against the CD18 surface antigenA new CHO (Chinese hamster ovary)-derived cell line expressing anti-TNFα monoclonal antibody with biosimilar potentialEvaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma DiagnosisStructural Changes in Stx1 Engineering Monoclonal Antibody Improves Its Functionality as Diagnostic Tool for a Rapid Latex Agglutination Test
P50
Q34167447-ED95C97B-3BF8-49EC-AB6E-91657BA2395AQ34566178-09FC2820-ACF0-40E7-9124-160DCE03E910Q34922631-C27A1E09-1C75-45D1-8F15-D6D3E0C0007CQ35043912-F8181DF7-BA11-4D6A-BFAC-7233888DB8A3Q35602239-25C8418B-41B5-42D6-8000-7477A29DA77AQ38364577-B0B57364-4BF9-4E02-8D80-5C8FA1A0DE43Q38743459-9BCF169D-6AAF-4ECC-B83E-44B9335D169EQ38812729-621020F2-C5AB-414C-AE06-5A1E723AC1A5Q38817851-AAEBC69D-1320-4290-AEDC-59822C221F8DQ39028961-0678F979-A33D-4D82-92AF-ACFBD90173A6Q39254681-9031BED8-2B03-4DA8-928B-78BEE7D0CAE1Q41585170-6C51267B-81A4-4CB0-B1B3-ACFAA1938E01Q46407612-A8BCD072-621C-4460-98F5-E806827184D4Q47715699-775DED96-E300-4DD0-9A5B-C0A91F08E0A7Q50331277-DBA543F4-DEEA-4ECB-AD86-35230570C2ECQ51774313-695B01D9-18AA-46C6-BCB6-0A599E45E43AQ51778389-DB9187F4-0B6F-4679-BB02-1A55BBFF1B23Q53840788-2A992012-1E0C-4A77-B150-D14DE5E3B3FBQ55480776-0DE7A5E8-2C61-4104-A557-82503F8F64C1Q58850749-D38581DC-0916-4E1C-BAEC-B622AF8965AAQ60361839-E365C883-06A1-4BFB-9900-93A554857339Q60921848-89258075-444C-466E-A020-2897E2AFC597Q61987477-7C0C062F-7650-4E3F-AF6A-55CE2A556593Q73842767-F7F52922-265F-4081-86FF-20CC6FA990F1Q88946789-AD43E956-4C4D-4EC5-9B9D-78348DFCAC1EQ89210474-53642113-238F-4475-8A72-313171716744Q90212175-086605BE-9346-41CD-89B2-3B96099A7E0E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana M Moro
@ast
Ana M Moro
@en
Ana M Moro
@es
Ana M Moro
@nl
Ana M Moro
@sl
type
label
Ana M Moro
@ast
Ana M Moro
@en
Ana M Moro
@es
Ana M Moro
@nl
Ana M Moro
@sl
prefLabel
Ana M Moro
@ast
Ana M Moro
@en
Ana M Moro
@es
Ana M Moro
@nl
Ana M Moro
@sl
P106
P21
P31
P496
0000-0002-0650-7764